NCT07103668 2025-10-23
A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Suzhou Immunofoco Biotechnology Co., Ltd
Phase 3 Recruiting
Clinical Trials
6 trialsNCT02144727 2016-04-20
ADDICT
National Cancer Center, Korea
Phase 3 Unknown
NCT02512380 2015-08-10
Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer
ChineseAMS
Phase 3 Unknown
NCT01989858 2015-01-29
ITACA-S2
Mario Negri Institute for Pharmacological Research
Phase 3 Terminated
NCT01283217 2013-06-04
Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer
Yonsei University
Phase 3 Unknown
NCT01583361 2012-04-24
RESONANCE
Chinese PLA General Hospital
Phase 3 Unknown